Hormonal Contraception and Risk of Chlamydia and Gonorrhea

• Status: Terminated
• Trial end date: 2001-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

There are biological reasons to suspect that hormones may affect the risk of a woman becoming infected with a sexually transmitted disease. The evidence on this issue to date is mixed and previous studies have methodologic flaws making it difficult to draw conclusions about the results.

This study compares the risk of developing either Chlamydial or Gonorrheal infection among three groups of women: those using combined oral contraceptives (birth control pills); those using the injectable hormone (brand name Depo Provera); and those women using non-hormonal contraceptive methods.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
• Treatments: Contraceptive Agents; Contraceptives, Oral; Contraceptives, Oral, Combined; Medroxyprogesterone; Medroxyprogesterone Acetate

Criteria

Inclusion Criteria:

• Female age 15 to 45 years

• no hormone use at enrollment

• not pregnant or planning pregnancy

Exclusion Criteria:

• Cervical cancer presently or in history

• hysterectomy, cone biopsy, or cervical cryotherapy